Compare AbCellera Biologics Inc (ABCL) vs Freshworks Inc (FRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Freshworks Inc — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while Freshworks Inc trades at $11.86 (market cap $3.31B). The key difference: AbCellera Biologics Inc and Freshworks Inc are close in size by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Freshworks Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | FRSH | |
|---|---|---|
Market Cap | $2.99B | $3.31B |
Sector | Health | Technology |
52-Week High | $9.76 | $13.97 |
52-Week Low | $2.78 | $6.88 |
Enterprise Value | $2.58B | $2.68B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Freshworks Inc
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →
